For optimum results, we recommend that you view this website on Google Chrome.

Our response to Covid-19

In these unprecedented times, the MoSMed community are continuing to support and engage with our Doctoral Researchers through regular online meetings and cohort catchups and supervisory interactions. Some of our amazing academic team have also been directly involved in and contributed to the testing programme associated with fighting the virus. 

We are delighted that members of the academic team and the Doctoral Researchers have been able to start returning to the labs on campus, and that their important research projects can now continue. We have been very impressed with the way that everyone has handled the disruption and uncertainty caused by Covid-19. We are also looking forward to welcoming our next cohort of Doctoral Researchers in the autumn 2021!

For further details regarding our partner universities’ response to the pandemic, please refer to the following webpages:

We are continuing to work remotely, but are contactable by email.

Stay safe,
The MoSMed Team


The EPSRC Centre for Doctoral Training (CDT) in Molecular Sciences for Medicine (MoSMed) is an EPSRC funded joint venture between Newcastle and Durham Universities.

CDTs provide training for a large cohort of PhD students in a single centre with significant added benefits above those provided by individual studentships. MoSMed provides a CDT experience for students focussed on research at the interface of chemistry and medicine.

Training of scientific leaders
Our CDT delivers a comprehensive research and training programme focussed on science at the interface of molecular and medical sciences, business skills, innovation and entrepreneurship.

High demand for Life Sciences researchers
The Life Sciences sector contributed more than £30bn to the economy in 2015. It supports half a million jobs in the UK and so there is a high demand for researchers trained in this area.
Molecular sciences such as chemistry, biophysics, molecular biology and protein science, are vital innovations in medicine and the discovery of new medicines and diagnostics.

Benefitting from partnerships with industry
Our CDT also benefits from partnerships, which include:

  • small, local biotech companies
  • large pharmaceutical companies
  • societal stakeholders

Two Institutes, One Campus
Our CDT will run as a single research programme across both Newcastle and Durham Universities to form an extended campus.
Students will benefit from the complementary research expertise of both institutions in an innovative training environment.